版本:
中国

BRIEF-NeoGenomics sees Q2 2017 adjusted earnings per share $0.03-$0.04

April 26 NeoGenomics Inc

* Neogenomics reports 15% volume growth and 10% reduction in average cost per test in the first quarter of 2017

* Q1 adjusted earnings per share $0.03

* Sees q2 2017 adjusted earnings per share $0.03 to $0.04

* Sees q2 2017 loss per share $0.03 to $0.04

* Sees q2 2017 revenue $62 million to $64 million

* Q1 revenue $61.7 million versus i/b/e/s view $61.6 million

* Q1 gaap loss per share $0.04

* Q1 earnings per share view $0.03 -- Thomson Reuters I/B/E/S

* Neogenomics inc sees full year consolidated 2017 revenue to be $255 - $265 million

* Neogenomics inc sees 2017 gaap diluted eps to be a loss of $0.10 - loss of $0.06 per share

* Neogenomics inc - expects adjusted ebitda to be $39 - $46 million for 2017

* Neogenomics inc sees adjusted diluted eps to be $0.17 - $0.21 per share for 2017

* Fy2017 earnings per share view $0.19, revenue view $264.6 million -- Thomson Reuters I/B/E/S

* Q2 earnings per share view $0.04, revenue view $66.0 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐